Give the holiday gift that can unlock the genome

Reykjavik, ICELAND, Dec. 19, 2007 – deCODE genetics (Nasdaq:DCGN) today announced the availability of deCODEme™ gift certificates that allow individuals to give the gift that enables friends and family to get a detailed look at their own genome.

Through a subscription to deCODEme™, friends and family members can learn what their DNA says about their ancestry and if they have genetic variants that have been associated with higher or lower than average risk of a range of common diseases.

Since our launch just a month ago, people throughout the world have subscribed to deCODEme™ and begun a journey of discovery through their own DNA.

“By offering gift certificates for deCODEme™, we are providing individuals with the opportunity to give a gift that can motivate a loved one and help to guide them in leading a healthier and more productive life” said Kari Stefansson, MD, PhD, CEO of deCODE. “This is an opportunity for individuals to learn what their genome says about themselves and their ancestry. Our genomes are all about us and our families – what better gift to give a loved one.”

The introductory promotional price of a subscription to deCODEme is $985. To learn more about deCODEme™ and how to order, visit

deCODEme™ – It’s all about you
deCODEme™ is a unique way to get to know yourself better – from the inside out. Our genomes are more than 99% identical, but in that one percent are millions of tiny variations that make you unique. Through deCODEme™ you can take steps toward learning how your genome makes you unique, in the context of cutting edge science and in ways that are both fascinating and informative. You can learn about your ancestry, about obvious and potentially quirky traits, and whether you have certain genetic variations that are known to be associated with an above or below average risk of certain common diseases. You can even decide with family and friends to compare genomes and discover which blocks of DNA code you share. As new discoveries are made, you will receive updates and be able to check your genome against the breakthroughs in the headlines.
When you open your deCODEme™ account you create your own username and password and have full control of information and data comparison with your friends and family. You can even create an anonymous account if you wish. And if you have questions, you can consult with our experts at no additional cost. Best of all, you have the peace of mind of knowing that deCODEme™ is offered by deCODE genetics – a proven leader in the field. When your DNA comes to us, our expert staff analyze it and post it to a secure web portal right here at deCODE. Neither your sample nor any of your data will be accessible to or shared with anyone but you and those that you designate.

About deCODE
deCODE genetics (Nasdaq:DCGN) is a global leader in applying human genetics to develop drugs and diagnostics for common diseases. Our population approach has enabled us to discover and target key biological pathways involved in conditions ranging from heart attack to cancer. We are turning these discoveries into new medicine to better treat and prevent many of the biggest challenges to public health. deCODE is delivering on the promise of the new genetics SM. Visit us on the web at, and on our diagnostics site at

Any statements contained in this presentation that relate to future plans, events or performance are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, among others, those relating to technology and product development, integration of acquired businesses, market acceptance, government regulation and regulatory approval processes, intellectual property rights and litigation, dependence on collaborative relationships, ability to obtain financing, competitive products, industry trends and other risks identified in deCODE’s filings with the Securities and Exchange Commission. deCODE undertakes no obligation to update or alter these forward-looking statements as a result of new information, future events or otherwise.

The deCODEme services are being offered by deCODE’s Icelandic subsidiary, deCODE genetics ehf.